Triple

T11074831
Position Surface form Disambiguated ID Type / Status
Subject APHINITY trial E261835 entity
Predicate drugTarget P37016 FINISHED
Object HER2 receptor E261824 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: HER2 receptor | Statement: [APHINITY trial, drugTarget, HER2 receptor]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: HER2 receptor
Context triple: [APHINITY trial, drugTarget, HER2 receptor]
  • A. HER2 receptor chosen
    The HER2 receptor is a cell surface protein and member of the epidermal growth factor receptor family that, when overexpressed, drives the growth of certain aggressive breast and other cancers.
  • B. ERBB2
    ERBB2, also known as HER2, is a receptor tyrosine kinase frequently overexpressed in certain breast and other cancers and serves as a key therapeutic target.
  • C. EGFR
    EGFR (epidermal growth factor receptor) is a transmembrane receptor tyrosine kinase that regulates cell growth and survival and is frequently implicated in cancer development and progression.
  • D. epidermal growth factor receptor family
    The epidermal growth factor receptor family is a group of closely related receptor tyrosine kinases (including EGFR/HER1, HER2, HER3, and HER4) that regulate cell growth, survival, and differentiation and are key targets in cancer biology and therapy.
  • E. ERBB4
    ERBB4 is a receptor tyrosine kinase of the ErbB/EGFR family involved in cell signaling pathways that regulate cell growth, differentiation, and development.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aa9983c08190b0ef61603b69feac completed April 8, 2026, 7:20 p.m.
NER Named-entity recognition batch_69d7994efb608190a81bc8c4d16ddbd0 completed April 9, 2026, 12:19 p.m.
NED1 Entity disambiguation (via context triple) batch_69e4832d59c08190ab120b991bc8ed3b completed April 19, 2026, 7:24 a.m.
Created at: April 8, 2026, 9:26 p.m.